Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Psychopharmacology (Oxford, England)|May 17, 2013
Naturalistic outcomes of community treatment orders: antipsychotic long-acting injections versus oral medicationMaxine X Patel, Jane Matonhodze, Mirza K Baig, et al.
Schizophrenia Bulletin|February 5, 2014
Dose equivalents for second-generation antipsychotics: the minimum effective dose methodStefan Leucht, Myrto Samara, Stephan Heres, et al.
Therapeutic Advances in Psychopharmacology|August 29, 2013
The knowledge and attitudes of psychiatrists towards antipsychotic long-acting injections in NigeriaBawo O James, Joyce O Omoaregba, Kingsley M Okonoda, et al.
Therapeutic Drug Monitoring|May 10, 2012
Risperidone and total 9-hydroxyrisperidone in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 2002-2010Sally V J Bowskill, Simon A Handley, Danielle S Fisher, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 5, 2014
Quality of prescribing for schizophrenia: evidence from a national audit in England and WalesMaxine X Patel, Delia Bishara, Simone Jayakumar, et al.
Journal of Clinical Psychopharmacology|June 23, 2011
Plasma olanzapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1999-2009Maxine X Patel, Sally Bowskill, Lewis Couchman, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 18, 2014
Assessment and treatment of physical health problems among people with schizophrenia: national cross-sectional studyMike J Crawford, Simone Jayakumar, Suzie J Lemmey, et al.
Schizophrenia Bulletin|April 5, 2015
Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose MethodStefan Leucht, Myrto Samara, Stephan Heres, et al.
BMC Psychiatry|March 15, 2020
Attitudes of European physicians towards the use of long-acting injectable antipsychoticsMaxine X Patel, Nawal Bent-Ennakhil, Christophe Sapin, et al.
Journal of Clinical Psychopharmacology|November 16, 2007
The effect of long-acting risperidone on working memory in schizophrenia: a functional magnetic resonance imaging studySimon A Surguladze, Elvina M Chu, Anthony Evans, et al.
Pageof 4